Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05624229Phase 4Not yet recruiting
Phase 4, randomised, open-label trial in Variceal bleeding (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: 5-day treatment failure rate. Planned start Oct 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05624229.